PharmAthene, Inc. (NYSEMKT:PIP) shares decline by 10.84%, Capstone Turbine Corporation (NASDAQ:CPST)

Posted by Michael Korte May 30, 2013 0 Comment 926 views


Hartford, CT 05/30/2013 (GDPInsider) – PharmAthene, Inc. (NYSEMKT:PIP) closed its day at $1.81 after heading 10.84% downwards, dropping by $0.22. It opened its day at $1.95 after its previous day close of $2.03. The intraday range of the stock is $1.77 low and $1.95 high. The average volume of the stock over a period of 90 days is 439.69K. With around 48.37 outstanding shares, the market capitalization of the company is $89.48 million. The relative volume of the shares is 5.89. The beta of the stock which measures the volatility is 1.63. The target price of the stock is 7.25. The 52-weeks share price range for the stock is $0.98- $2.20. The current ratio 2.64, which is high, shows healthy liquidity and ability to deal with short-term debts.

PharmAthene is experiencing a breakout in the volume of shares. It has been in a legal battle with SIGA Technologies where the Delaware Supreme Court has reversed the award and handed the case over to Court of Chancery where the final verdict would be given.
Is PIP a solid investment at these levels?
Get valuable updates and exclusive insights here.

Capstone Turbine Corporation (NASDAQ:CPST) closed its day at $1.14 after heading 2.56% downwards, dropping by $0.03. It opened its day at $1.17 after its previous day close of $1.17. The intraday range of the stock is $1.09 low and $1.18 high. The average volume of the stock over a period of 90 days is 2.18 million. With around 304.57 million outstanding shares, the market capitalization of the company is $343.95 million. The relative volume of the shares is 7.26. The beta of the stock which measures the volatility is 1.64. The target price of the stock is 1.75. The 52-weeks share price range for the stock is $0.73- $1.20. The current ratio 1.74, which is high, shows healthy liquidity and ability to deal with short-term debts.

Capstone Turbine has recently announced that it has received a high order from the company of New York based related companies.

How Should Investors Trade CPST Now? Get key and important information right here.

Disclosure:

WallStreetAnalyzed.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetAnalyzed.com website, for complete risks and disclosures.


About Michael Korte

Michael Korte an investigative reporter at GDP Insider and is a breaking news reporter. Michael work includes investigations of misconduct by federal prosecutors and industrial air pollution around the nation's schools. His reporting has been recognized with the Hillman Prize for Newspaper Journalism, the Grantham Prize for Excellence in Reporting on the Environment, and the Philip Meyer Journalism Award for reporting that incorporates social science methods.

View all post by Michael Korte Visit author's website

Write Your Comment